Former Pfizer CEO Kindler joins Lux Capital

Thu Aug 9, 2012 6:27am IST

Stocks

   

Aug 8 (Reuters) - Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner, Lux said in a statement, where he will help scout for healthcare investment opportunities and work with portfolio companies.

Kindler retired from Pfizer in December 2010 after eight years with the company and was replaced as CEO by Ian Read.

Apart from his new role at Lux Capital, Kindler also serves on the board of several other pharmaceutical and healthcare companies. He is also a member of U.S. President Barack Obama's management advisory board and a director at private equity firm Starboard Capital Partners.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Healthcare Corruption

REUTERS SHOWCASE

Short of Expectations

Short of Expectations

Apple revenue lags Street's view despite strong China growth  Full Article 

Mircosoft Results

Mircosoft Results

Microsoft revenue rises, profit falls as Nokia absorbed  Full Article 

Deal Talk

Deal Talk

Exclusive - Lupin, U.S. firms weigh bids for GSK's mature drugs: sources  Full Article 

Relief For Sahara

Relief For Sahara

Supreme Court could allow Sahara boss to conduct asset sale talks, company says.  Full Article 

Classifying Banks

Classifying Banks

RBI to start announcing too-big-to-fail banks in Aug 2015  Full Article 

Food Scandal

Food Scandal

Starbucks, Burger King dragged in as China food scandal spreads.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage